本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

GT Biopharma Inc.

2.10
+0.04001.94%
成交量:8.16万
成交额:17.16万
市值:661.08万
市盈率:-0.38
高:2.21
开:2.04
低:2.02
收:2.06
数据加载中...
2021/04/23

SEC问询函

CORRESP [Cover] - Correspondence
2021/04/22

招股说明书

S-1 - General form for registration of securities under the Securities Act of 1933
2021/04/16

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/04/16

重要事件披露

8-K - Current report
2021/04/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/22

重要事件披露

8-K - Current report
2021/02/18

重要事件披露

8-K - Current report
2021/02/17

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/17

重要事件披露

8-K - Current report
2021/02/11

重要事件披露

8-K - Current report
2021/02/09

SEC问询函

CORRESP [Cover] - Correspondence
2021/02/09

重要事件披露

8-K - Current report
2021/02/09

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/02/08

SEC问询函

CORRESP [Cover] - Correspondence
2021/02/08

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/02/08

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/05

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/02

重要事件披露

8-K - Current report
2021/02/02

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/01/19

重要事件披露

8-K - Current report